EFMOROCTOCOG ALFA for Factor viii deficiency: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 832 adverse event reports in the FDA FAERS database where EFMOROCTOCOG ALFA was used for Factor viii deficiency.
Most Reported Side Effects for EFMOROCTOCOG ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemorrhage | 836 | 45.6% | 1 | 100 |
| Traumatic haemorrhage | 139 | 7.6% | 0 | 28 |
| Arthralgia | 137 | 7.5% | 1 | 23 |
| Limb injury | 120 | 6.6% | 0 | 13 |
| Fall | 114 | 6.2% | 1 | 26 |
| Haemarthrosis | 114 | 6.2% | 0 | 11 |
| Spontaneous haemorrhage | 99 | 5.4% | 0 | 13 |
| Joint injury | 97 | 5.3% | 0 | 15 |
| Contusion | 73 | 4.0% | 0 | 5 |
| Head injury | 67 | 3.7% | 0 | 15 |
| Pain | 61 | 3.3% | 0 | 15 |
| Epistaxis | 53 | 2.9% | 0 | 6 |
| Off label use | 52 | 2.8% | 0 | 4 |
| Pain in extremity | 49 | 2.7% | 0 | 11 |
| Weight increased | 48 | 2.6% | 0 | 16 |
Other Indications for EFMOROCTOCOG ALFA
Haemorrhage (219)
Prophylaxis (61)
Immune tolerance induction (46)
Product used for unknown indication (46)
Haemophilia (34)
Haemorrhage prophylaxis (22)
Haemarthrosis (10)
Other Drugs Used for Factor viii deficiency
EMICIZUMAB-KXWH (6,532)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (4,268)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (722)
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (352)
ANTI-INHIBITOR COAGULANT COMPLEX (317)
EMICIZUMAB (315)
DAMOCTOCOG ALFA PEGOL (310)
EFANESOCTOCOG ALFA (292)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (180)
ANTIHEMOPHILIC FACTOR HUMAN (161)